Richard E Pratley

Summary

Affiliation: Florida Hospital
Country: USA

Publications

  1. doi request reprint The early treatment of type 2 diabetes
    Richard E Pratley
    Florida Hospital Diabetes and Translational Research Institute, Sanford Burnham Medical Research Institute, Orlando, Fla Electronic address
    Am J Med 126:S2-9. 2013
  2. doi request reprint Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6)
    R E Pratley
    Florida Hospital Sanford Burnham Translational Research Institute for Metabolism and Diabetes, Orlando, FL, USA
    Diabetes Obes Metab 15:234-40. 2013
  3. pmc Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial
    Richard E Pratley
    Diabetes Institute, Florida Hospital, Orlando, Florida, USA
    Diabetes Care 35:1986-93. 2012
  4. doi request reprint Clinical management of elderly patients with type 2 diabetes mellitus
    Richard E Pratley
    Florida Hospital Diabetes Institute, Sanford Burnham Medical Research Institute, Orlando, FL 32804, USA
    Postgrad Med 124:133-43. 2012

Detail Information

Publications4

  1. doi request reprint The early treatment of type 2 diabetes
    Richard E Pratley
    Florida Hospital Diabetes and Translational Research Institute, Sanford Burnham Medical Research Institute, Orlando, Fla Electronic address
    Am J Med 126:S2-9. 2013
    ....
  2. doi request reprint Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6)
    R E Pratley
    Florida Hospital Sanford Burnham Translational Research Institute for Metabolism and Diabetes, Orlando, FL, USA
    Diabetes Obes Metab 15:234-40. 2013
    ..This study compared the efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes inadequately controlled with sulphonylurea ± metformin...
  3. pmc Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial
    Richard E Pratley
    Diabetes Institute, Florida Hospital, Orlando, Florida, USA
    Diabetes Care 35:1986-93. 2012
    ..To assess the efficacy and safety of switching from sitagliptin to liraglutide in metformin-treated adults with type 2 diabetes...
  4. doi request reprint Clinical management of elderly patients with type 2 diabetes mellitus
    Richard E Pratley
    Florida Hospital Diabetes Institute, Sanford Burnham Medical Research Institute, Orlando, FL 32804, USA
    Postgrad Med 124:133-43. 2012
    ....